In this context, whole tumor cell lysates are excellent sources for the delivery of a wide range of TAAs that will generate MHC class I/II T cell epitopes for inducing the activation of CD4+ T helper and CD8+ cytotoxic T cells simultaneously, and therefore, a more integral immune response. The gene discussed is CD4; the disease is neoplasm.